Oak mistletoe / Silver carbonate solution for injection 1ml ampoules
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
7 branded products available
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 1 · 1918–2026
Showing the 50 most relevant studies, sorted by most relevant.
Wan-Taek Lim, Chang‐Eui Hong, Su‐Yun Lyu
Scientia Pharmaceutica, 2023
Annika Mascher, Florian Pelzer, Lorna Duncan, et al.
Integrative Cancer Therapies, 2023
- Neoplasms
- Mistletoe
- Viscum album
P. Lech, A. Żółciak, R. Hildebrand
Forests, 2020
Lucjan Rutkowski, Andrzej Nienartowicz, Mieczysław Kunz
Ecological Questions, 2023
The paper presents the distribution of localities of seven tree taxa, identified as new hosts of mistletoe in Poland, in the city of Toruń. Particular attention was paid to the description of a site with mistletoe on an oak identified as Quercus x rosacea. The reason for this is that native oaks are rare hosts of mistletoe in Central and Eastern Europe and this is the first finding of such a host–parasite association in Poland. The occurrence of all eight host species at 14 sites was compared with the distribution and description of localities and morphological characteristics of both host–mistletoe association components presented in the botanical, ecological and forestry literature.
Abstract licence: CC BY-ND 4.0
Kyeong Tae Park, Jong Bae Seo, Kyung Hee Kim
Human Ecology Research, 2025
Jiří Doležal, Vojtěch Lanta, Kirill Korznikov, et al.
2025
David C. Shaw, Max Bennett, Don Goheen, et al.
Northwest Science, 2026
Girma Altaye, Ashefet Agete, Ebrahim Talebi
2023
Abstract This study delves into the impact of seasonal variations on the diversity of endophytic fungi inhabiting the foliage of Grevillea robusta trees along highways in Hawassa City, Ethiopia. With 765 fungal isolates categorized into 73 distinct morphotaxa, 90.41% were identified across eight known genera, leaving 9.58% unidentified. Notably, Phoma and Pestalotiopsis emerged as the most diverse genera, presenting 13 and 11 morphotaxa respectively, while Alternaria and Xylaria showed lower diversity with 3 and 2 morphotaxa each. The research unveiled heightened fungal counts and diversity in trees situated in more polluted environments, leaves sampled during dry seasons, those exhibiting signs of disease, lower leaf sections, and midrib samples. These findings underscore the rich assortment of endophytic fungi associated with Grevillea robusta leaves within roadside plantations in Hawassa City, emphasizing the need for further exploration of this fungal community's dynamics. Understanding the pivotal role of these endophytic fungi in tree health, ecosystem resilience, and potential applications in agriculture, forestry, and biotechnology remains imperative.
Abstract licence: CC BY 4.0
E. Gillerman, D. H. Whitebread
Trace Elements Investigations, 1953
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.